1-7 of 7
Ishan Hirji, MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Baseline Characteristics Of Patients With Chronic Myeloid Leukemia In a Prospective Observational Study (SIMPLICITY)

Jorge E. Cortes, MD, Rüdiger Hehlmann, MD, Carlo Gambacorti-Passerini, MD, Stuart Goldberg, MD, H. Jean Khoury, MD, Michael Mauro, MD, Mauricette Michallet, MD, PhD, Ron Paquette, MD, PhD, Bengt Simonsson, MD, PhD, Aimee Foreman, PhD, Hesham Mohamed, MD, Teresa Zyczynski, Pharm.D., MPH, Ishan Hirji, MPH, Catherine Davis, Pharm.D.
Journal: Blood
Blood (2013) 122 (21): 4026.
https://doi.org/10.1182/blood.V122.21.4026.4026
Published: 2013
Journal Articles

Associations Between Treatment Restrictions, Patient-Reported Treatment Burden and Adherence to Tyrosine-Kinase Inhibitor Therapy Among Chronic Myeloid Leukemia Patients in the United States and Europe

Shaloo Gupta, M.S., Amir Goren, Ph.D., Timothy W Victor, Ph.D., Jonathan Chapnick, Stephanie Hawthorne, PhD, Ishan Hirji, MPH, Eduardo Olavarría, MD, Alyson B Moadel, Ph.D., Colleen Lemoine, APRN, MN, AOCN, RN-BC, Catherine Davis, Pharm.D.
Journal: Blood
Blood (2011) 118 (21): 2077.
https://doi.org/10.1182/blood.V118.21.2077.2077
Published: 2011
Journal Articles

Treatment Adherence in Patients with Chronic Myeloid Leukemia in a Real World Setting

Susan A Oliveria, ScD, MPH, FISPE, Marianne Ulcickas Yood, DSc, MPH, FISPE, Ishan Hirji, MPH, Syd Phillips, MPH, Mark Cziraky, PharmD, FAHA, CLS, Catherine Davis, Pharm.D.
Journal: Blood
Blood (2011) 118 (21): 4424.
https://doi.org/10.1182/blood.V118.21.4424.4424
Published: 2011
Journal Articles

Quality of Life During Early Tyrosine Kinase Inhibitor Treatment As Self-Reported by Chronic Myeloid Leukemia Patients Participating in a Prospective Observational Study (SIMPLICITY)

Jorge E. Cortes, Michael J. Mauro, MD, Stuart L. Goldberg, MD, Ron Paquette, MD, PhD, H. Jean Khoury, MD, FACP, Ishan Hirji, MPH, Samuel Wagner, PhD, RPh, Sam Joo, PhD, Catherine Davis, PharmD
Journal: Blood
Blood (2011) 118 (21): 4435.
https://doi.org/10.1182/blood.V118.21.4435.4435
Published: 2011
Journal Articles

Comorbidities and Conmedication Use In Patients with Chronic Myelogenous Leukemia.

Susan A Oliveria, ScD, MPH, Marianne Ulcickas Yood, DSc, MPH, Ishan Hirji, MPH, Mark Cziraky, PharmD, FAHA, CLS, Catherine Davis
Journal: Blood
Blood (2010) 116 (21): 4492.
https://doi.org/10.1182/blood.V116.21.4492.4492
Published: 2010
Journal Articles

Adherence to Treatment In Patients with Chronic Myelogenous Leukemia During a 10-Year Time Period: A Medical Record Review.

Marianne Ulcickas Yood, DSc, MPH, Susan A Oliveria, ScD, MPH, Ishan Hirji, MPH, Mark Cziraky, PharmD, FAHA, CLS, Catherine Davis
Journal: Blood
Blood (2010) 116 (21): 1235.
https://doi.org/10.1182/blood.V116.21.1235.1235
Published: 2010
Journal Articles

Evaluation of Trends in Imatinib Dosing over Time: A Retrospective Cohort Study.

Muhammad Hamdan, MD, Marianne Ulcickas Yood, DSc, MPH, Lynn M. Sanders, MPH, Ishan Hirji, MPH, Tracey Hoy, BS, Susan A. Oliveria, ScD, MPH
Journal: Blood
Blood (2005) 106 (11): 3117.
https://doi.org/10.1182/blood.V106.11.3117.3117
Published: 2005